COLLABORATIVE RESEARCH AND LICENSE AGREEMENTCollaborative Research and License Agreement • May 6th, 2005 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (the “Agreement”) is entered into as of January 18, 2005 by and between RIGEL PHARMACEUTICALS, INC., a Delaware corporation with its offices at 1180 Veterans Boulevard, South San Francisco, California 94080 (“Rigel”), and PFIZER INC., a Delaware corporation with its offices at 235 East 42nd Street, New York, New York 10017 (“Pfizer”). Rigel and Pfizer may be referred to herein individually as a “Party” or collectively, as the “Parties.”
